Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss RARE - Ultragenyx Pharmaceutical Inc.
647 K
LAST VALUE
56.87%
2 YEAR CAGR
24.76%
5 YEAR CAGR
50.30%
10 YEAR CAGR